These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20424269)

  • 1. Absence of adipose differentiation related protein upregulates hepatic VLDL secretion, relieves hepatosteatosis, and improves whole body insulin resistance in leptin-deficient mice.
    Chang BH; Li L; Saha P; Chan L
    J Lipid Res; 2010 Aug; 51(8):2132-42. PubMed ID: 20424269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.
    Imai Y; Varela GM; Jackson MB; Graham MJ; Crooke RM; Ahima RS
    Gastroenterology; 2007 May; 132(5):1947-54. PubMed ID: 17484887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein.
    Chang BH; Li L; Paul A; Taniguchi S; Nannegari V; Heird WC; Chan L
    Mol Cell Biol; 2006 Feb; 26(3):1063-76. PubMed ID: 16428458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
    Matsusue K; Haluzik M; Lambert G; Yim SH; Gavrilova O; Ward JM; Brewer B; Reitman ML; Gonzalez FJ
    J Clin Invest; 2003 Mar; 111(5):737-47. PubMed ID: 12618528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice.
    Yahagi N; Shimano H; Hasty AH; Matsuzaka T; Ide T; Yoshikawa T; Amemiya-Kudo M; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Osuga J; Harada K; Gotoda T; Nagai R; Ishibashi S; Yamada N
    J Biol Chem; 2002 May; 277(22):19353-7. PubMed ID: 11923308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing roles of cell death-inducing DFF45-like effector B and perilipin 2 in controlling hepatic VLDL lipidation.
    Li X; Ye J; Zhou L; Gu W; Fisher EA; Li P
    J Lipid Res; 2012 Sep; 53(9):1877-89. PubMed ID: 22661308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice.
    Xu J; Donepudi AC; More VR; Kulkarni SR; Li L; Guo L; Yan B; Chatterjee T; Weintraub N; Slitt AL
    Obesity (Silver Spring); 2015 Feb; 23(2):335-44. PubMed ID: 25451536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
    Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
    Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, steatohepatitis, and hepatocellular carcinoma in a new congenic strain of Fatty Liver Shionogi (FLS) mice with the Lep(ob) gene.
    Soga M; Hashimoto S; Kishimoto Y; Hirasawa T; Makino S; Inagaki S
    Exp Anim; 2010; 59(4):407-19. PubMed ID: 20660987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
    Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
    J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice.
    Chen Z; Newberry EP; Norris JY; Xie Y; Luo J; Kennedy SM; Davidson NO
    J Lipid Res; 2008 Sep; 49(9):2013-22. PubMed ID: 18519977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.
    Perfield JW; Ortinau LC; Pickering RT; Ruebel ML; Meers GM; Rector RS
    J Obes; 2013; 2013():296537. PubMed ID: 23401753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.
    López-Parra M; Titos E; Horrillo R; Ferré N; González-Périz A; Martínez-Clemente M; Planagumà A; Masferrer J; Arroyo V; Clària J
    J Lipid Res; 2008 Dec; 49(12):2513-23. PubMed ID: 18645210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance.
    Bell M; Wang H; Chen H; McLenithan JC; Gong DW; Yang RZ; Yu D; Fried SK; Quon MJ; Londos C; Sztalryd C
    Diabetes; 2008 Aug; 57(8):2037-45. PubMed ID: 18487449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic CCAAT/enhancer binding protein alpha mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice.
    Matsusue K; Gavrilova O; Lambert G; Brewer HB; Ward JM; Inoue Y; LeRoith D; Gonzalez FJ
    Mol Endocrinol; 2004 Nov; 18(11):2751-64. PubMed ID: 15319454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity.
    Wendel AA; Li LO; Li Y; Cline GW; Shulman GI; Coleman RA
    Diabetes; 2010 Jun; 59(6):1321-9. PubMed ID: 20200319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose differentiation-related protein regulates lipids and insulin in pancreatic islets.
    Faleck DM; Ali K; Roat R; Graham MJ; Crooke RM; Battisti R; Garcia E; Ahima RS; Imai Y
    Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E249-57. PubMed ID: 20484013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.